- Adamis Pharmaceuticals (NASDAQ:ADMP) trade low, down 8%, despite regaining Nasdaq compliance.
- The company had received the letter as it failed to file for quarterly reports, Form 10-Q for the periods ended March 31, 2021, June 30, 2021 and September 30, 2021.
Adamis Pharmaceuticals regains Nasdaq compliance
Recommended For You
More Trending News
About DMKPQ Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
DMKPQ | - | - |
DMK Pharmaceuticals Corporation |